Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by knowsbeston Jan 24, 2022 2:08pm
221 Views
Post# 34354209

Losers order 1 CERIAL 2 CATS 3 ABOVE

Losers order 1 CERIAL 2 CATS 3 ABOVE NO ..they are just the guard dogs . THE REAL #1LOSER IS THE FOOKER ..still doing what he does best ...poop ..poop ...poop ..SO FUNNY ..MY PARTNER LOVES IT 

@Aproudcanadian Journey toward March 15th should be interesting. Right now Medivolve has $40 million revenue for 3 quarters and with 4th quarter results announcement it should reach $60 to $70 million. That will be double or even more than double to current market cap.
 
2
 
@foodstampking *should double
 
1
 
@Aproudcanadian Then comes the 1st quarter results making it triple or even more than triple revenue to current market cap. Let's see how long market can ignore that. Lol
 
3
 

<< Previous
Bullboard Posts
Next >>